1-2 of 2
Eric O'Neill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

89Zr-anti-γH2AX-TAT but not 18F-FDG Allows Early Monitoring of Response to Chemotherapy in a Mouse Model of Pancreatic Ductal Adenocarcinoma

James C. Knight, Michael J. Mosley, Luisa Contreras Bravo, Veerle Kersemans, P. Danny Allen, Somnath Mukherjee, Eric O'Neill, Bart Cornelissen
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (21): 6498–6504.
https://doi.org/10.1158/1078-0432.CCR-17-0664
Published: 31 October 2017
View article titled, <sup>89</sup>Zr-anti-γH2AX-TAT but not <sup>18</sup>F-FDG Allows Early Monitoring of Response to Chemotherapy in a Mouse Model of Pancreatic Ductal Adenocarcinoma
Open the PDF for <sup>89</sup>Zr-anti-γH2AX-TAT but not <sup>18</sup>F-FDG Allows Early Monitoring of Response to Chemotherapy in a Mouse Model of Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway

Lana McClements, Anita Yakkundi, Angelos Papaspyropoulos, Hannah Harrison, Matthew P. Ablett, Puthen V. Jithesh, Hayley D. McKeen, Rachel Bennett, Christopher Donley, Adrien Kissenpfennig, Stuart McIntosh, Helen O. McCarthy, Eric O'Neill, Robert B. Clarke, Tracy Robson
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 3881–3893.
https://doi.org/10.1158/1078-0432.CCR-13-0595
Published: 15 July 2013
View article titled, Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
Open the PDF for Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway in another window
Includes: Supplementary data